Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
ALS (Amyotrophic Lateral Sclerosis): early-phase trial registry
5 of 7 indexed ALS (Amyotrophic Lateral Sclerosis) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
ALS (Amyotrophic Lateral Sclerosis): 7 US clinical trials tracked, 5 recruiting.
ALS (Amyotrophic Lateral Sclerosis) is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Desin, running 1 of these trials.
Enrollment posture brief
Registry condition als-amyotrophic-lateral-sclerosis
OPEN 5 | RECR 71% | LATE 0 | EARLY 2 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
ALS (Amyotrophic Lateral Sclerosis) lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for ALS (Amyotrophic Lateral Sclerosis) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
ALS (Amyotrophic Lateral Sclerosis) is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of ALS (Amyotrophic Lateral Sclerosis) trials is spread across many organizations.
Desin accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most ALS (Amyotrophic Lateral Sclerosis) trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
ALS (Amyotrophic Lateral Sclerosis) research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
ALS Research Collaborative
ALS Therapy Development Institute
NCT06885918
Clinical Outcome Assessment for AT & BCI
Shirley Ryan AbilityLab
NCT07407725
Tofersen in Non-SOD1 ALS
Washington University School of Medicine
NCT07294144
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
PathMaker Neurosystems
NCT06649955
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
Cognixion
NCT06810219
Obi Medical Robot: Evaluating Effectiveness Related to Usability
Desin
NCT07151950
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
Massachusetts General Hospital
NCT07047209
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on ALS (Amyotrophic Lateral Sclerosis) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on ALS (Amyotrophic Lateral Sclerosis) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this ALS (Amyotrophic Lateral Sclerosis) page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 ALS (Amyotrophic Lateral Sclerosis) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Desin sponsors the most ALS (Amyotrophic Lateral Sclerosis) trials on record, review their full trial history before evaluating a specific study. See Desin's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This ALS (Amyotrophic Lateral Sclerosis) condition card totals 7 registered trials; most-linked intervention One-week trial of Obi Medical device, which provides robotic assistance with feeding to persons with upper extremity impairments who are unable to self-feed in the traditional manner using utensils; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.